From: Recent advances on the role of host factors during non-poliovirus enteroviral infections
Drug compound | Virus | Mode of action | Reference |
---|---|---|---|
Andrographolide | EV-D68 | Suppresses maturation of the virus within the acidic endosomes. | [182] |
DTriP | EV-A71 | Blocks viral replication by targeting the RNA dependent RNA polymerase. | [195] |
Ribavirin | EV-A71 | General reduction of the viral yield | [179] |
Quercetin | EV-A71 | Inhibits virus attachment, adsorption and the viral 3C protease | [180] |
Rupintrivir | EV-A71, CV-A16, HRV | Binds and inhibits viral 3C protease activity | |
Fluoxetine | CV-B3 | Reduces synthesis of viral RNA and protein | [199] |
Dibucaine | CV-B3, EV-D68, | RNA replication stage; may be targeting CV-B3 viral 2C protease | [184] |
Formoterol | CV-B3, EV-D68, EV-A71, RV-A2, RV-B14 | Likely inhibit RV-14 by reducing ICAM-1 levels or acidic endosomes. | |
Pirlindole | EV-D68 and CV-B3 | RNA replication stage; may be targeting CV-B3 viral 2C protease | Â |
Budesonide | RV-14 | Â | [200] |
Zuclopenthixol | EV-D68 and CV-B3 | RNA replication stage; may be targeting CV-B3 viral 2C protease | [184] |
Apigenin | EV-A71 | Targeting viral IRES thereby inhibiting viral translation process |